ArticleFrontiers in pediatrics2025
Association between vitamin B
Article in Frontiers in pediatrics, 2025. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 1 paper.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
1 citing paper in PubMed.
- Article
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
2 authors.
Funding
No grant is acknowledged in the PubMed record.
Abstract
Aim: There are few studies investigating the relationship between vitamin B6 status and the odds of eczema in children and adolescents. Hereby, this study aims to explore the association between vitamin B6 status and eczema in children and adolescents. Methods: A cross-sectional study was conducted based on National Health and Nutrition Examination Surveys (NHANES) 2005-2006. The vitamin B6 status was assessed based on levels of 4-PA, PLP and vitamin B6 metabolic rate (4-PA/PLP) by high-performance liquid chromatography. The weighted univariate and multivariate logistics regression models were adopted to explore the association between vitamin B6 status with and the odds of eczema in children and adolescents, with odds ratio (ORs) and 95% confidence intervals (CIs). The subgroup analysis based on age, gender, atopy and body mass index (BMI) were further performed to explore whether the association between vitamin B6 status and eczema in children and adolescents remains robust. Results: A total of 2,256 eligible children and adolescents were included for further analysis, with the mean aged of 11.81 (±0.09) years old. Among them, 247 (10.95%) had eczema. After adjusted all covariates, we observed high 4-PA was associated with high odds of eczema (OR = 1.57, 95%CI: 1.01-2.44, Conclusion: Our study observed that high 4-PA and high vitamin B6 metabolic rate were associated with increased odds of eczema in children and adolescents. Maintaining high vitamin level may have potential benefits in reducing odds for eczema in children and adolescents.
Indexed as
Identifiers
What OpenQuestion holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.